Ilizarov Treatment of Congenital Pseudarthrosis of the Tibia: A Multi-Targeted Approach Using the Ilizarov Technique by Choi, In Ho et al.
Ilizarov Treatment of Congenital Pseudarthrosis of 
the Tibia: A Multi-Targeted Approach Using the 
Ilizarov Technique
In Ho Choi, MD, Tae-Joon Cho, MD, Hyuk Ju Moon, MD
Depatment of Orthopaedic Surgery, Seoul National University Children’s Hospital, Seoul National University College of Medicine, Seoul, Korea
Review Article    Clinics in Orthopedic Surgery 2011;3:1-8   •  doi:10.4055/cios.2011.3.1.1
Copyright © 2011 by The Korean Orthopaedic Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Clinics in Orthopedic Surgery • pISSN 2005-291X    eISSN 2005-4408
Received June 23, 2010; Accepted June 29, 2010
Correspondence to: In Ho Choi, MD
Department of Orthopaedic Surgery, Seoul National University Children’s 
Hospital, 28 Yeongeon-dong Jongno-gu, Seoul 110-744, Korea
Tel: +82-2-2072-3640, Fax: +82-2-745-3367
E-mail: inhoc@snu.ac.kr
Congenital pseudarthrosis of the tibia (CPT) is not a 
homogeneous entity but is composed of several disease 
types
1,2) with different prognoses.
3-6) The precise cause of 
CPT is unclear, even though it appears to be related to 
neurofibromatosis-1 (NF-1). The natural history of CPT 
varies and is unpredictable,
1,2,7) and no surgical or medical 
option appears to be capable of altering its natural history 
or pathobiology. The treatment aims are to achieve bony 
union without axial or rotational malalignment, stabilize 
the ankle mortise for good foot and ankle function, and 
achieve lower limb-length equalization. In atrophic-type 
CPT, these goals are extremely difficult to accomplish. 
However, primary union appears to have been improved 
markedly by modern treatment methods, such as, in-
tramedullary fixation,
8-11) microvascular transfer of a 
fibular graft,
12,13) and external fixation using the Ilizarov 
technique.
4-6,14-18) Nevertheless, regardless of the surgical 
options, the basic biological considerations of surgery are 
the same; pseudarthrosis resection, biological bone bridg-
ing of the defect with stable fixation, and correction of any 
angular deformity. However, residual challenges are com-
monly encountered and are perplexing. Moreover, occa-
sionally, the residual problems encountered after primary 
union may be severe enough to jeopardize function of 
the affected extremity, particularly in atrophic-type CPT. 
Therefore, to obtain a stable, functional extremity at the 
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completion of treatment, it is essential to set realistic goals 
and to adhere to the treatment principles and technical 
details. This review discusses how to accomplish multiple 
targets using the Ilizarov technique while minimizing the 
residual challenges after primary healing. 
ILIZAROV TREATMENT
The Ilizarov method was introduced in the western world 
during the late 1980s, and has been widely popularized 
and applied to the treatment of CPT, because it can ad-
dress pseudarthrosis as well as all components of the 
complex deformities associated with this condition. Fur-
thermore, in contrast to other treatment modalities, the 
Ilizarov technique is not precluded by previous surgery, 
and the Ilizarov device can be reapplied in the event of re-
fracture.
5,15) The technique is particularly beneficial when 
other methods have failed or in patients with angulation 
threatening refracture, shortening exceeding 5 cm, late 
symptomatic ankle or proximal tibial valgus, proximal 
fibular migration, or procurvatum producing a severe cal-
caneus-type gait.
19) In addition, because the Ilizarov tech-
nique rarely burns bridges,
20) all other conventional treat-
ment modalities are still possible if this technique fails. If 
necessary, a combination of two or three techniques can be 
used sequentially or simultaneously in an effort to obtain 
union. For example, a free vascularized fibula graft can be 
combined using the Ilizarov technique, thereby offering 
the advantage of addressing both bone loss and leg length 
inequality.
21) For these reasons, many surgeons agree that 
the Ilizarov method is a viable surgical alternative. How-
ever, it is not the ultimate solution for all types of CPT.
A variety of techniques based on several different 
frame configurations and strategies have been reported 
for the Ilizarov method.
4-6,17,18,22,23) Although the primary 
aim of treatment is union of the pseudarthrosis site, the 
therapeutic considerations should include other associated 
problems, such as leg-length discrepancy, multilevel and 
multidirectional tibial deformity, foot deformity, associated 
fibular pseudarthrosis and subsequent ankle valgus.
22,24,25) 
According to the literatures produced by retrospective 
case series, the overall union rate for the Ilizarov technique 
ranges from 60 to 100%.
20) However, the union rate and 
function after an Ilizarov treatment can be confounded by 
a variety of factors, such as the severity of dysplasia, failed 
previous treatments, and co-existing deformities. 
The basic principles of the Ilizarov treatment for 
atrophic-type CPT include the following: a) meticulous 
and complete resection of the sclerotic bone edges and 
surrounding fibrous hamartoma, and reopening of the 
medullary canals; b) the restoration and maintenance of 
axial alignment and joint orientation by correcting all an-
gular deformities; c) maximization of the cross-sectional 
area of healing at the level of the pseudarthrosis; d) ankle 
stabilization to prevent deformities around the ankle, such 
as ankle valgus and procurvatum of the distal tibia; e) 
stable construction of the ring fixator coupled with trans-
fixing wires as far from the sclerotic lesion as possible; f) 
protective bracing or intramedullary nailing to prevent re-
fracture after primary bone healing; and g) length-gain by 
distraction osteogenesis, preferably to < 2-3 cm of shorten-
ing, such that the residual discrepancies can be managed 
by shoe lifting and contralateral epiphysiodesis. 
COMPLICATIONS AND RESIDUAL CHALLENGES
Complications attributable to treatment and the disease 
have been recognized. The complications related primarily 
to the use of an external device include pin-track infection, 
loosening, breakage, refracture at the pin insertion site, 
neurovascular injury, axial deviation, osteopenia and joint 
stiffness. Residual limb length discrepancy and valgus de-
formity are commonly reported with an overall complica-
tion rate of 30 to 100%.
4,16)
Refracture is the most serious complication that may 
result in the re-establishment of pseudarthrosis. Indeed, 
there is a CPT subgroup that continues to cause refracture 
due to severe dysplasia.
19) With regard to the risk factors 
of refracture after initial union in CPT, a younger age at 
surgery, low cross-sectional area of the healed segment, tu-
mor recurrence, persistent fibular pseudarthrosis, residual 
ankle valgus, removal of an intramedullary rod, and non-
compliance with bracing have been suggested.
22,26) Inan et 
al.
27) reviewed the residual deformities in 16 patients treat-
ed for CPT. Ten had diaphyseal malalignment, of which 
half experienced refracture. In another series, in which an 
intramedullary rod was used, Fern et al.
28) reported a 40% 
refracture rate after 4.5 years, and Joseph and Mathew
29) 
reported a 25% refracture rate after 3 years. We also inves-
tigated the patterns of refracture and their risk factors in 
23 patients with atrophic-type CPT. Twenty patients had 
refracture after initial union.
26) The refracture-free rate 
of cumulative survival was 47% at five years and did not 
change thereafter. The risk of refracture was significantly 
higher when osteosynthesis was performed below the age 
of four years, when the tibial cross-sectional area was low, 
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CONSIDERATIONS OF THE FACTORS THAT 
MINIMIZE THE RESIDUAL CHALLENGES
Age 
Some prognostic factors for CPT have been reported but 
there is considerable controversy, e.g., whether or not there 
is a correlation exists between the age at surgery and the 
final outcome. Although some authors have claimed that 
surgery under 3 to 4 years of age is beneficial,
18,30) many 
others
16,31) have recommended waiting until the child is 
5 to 6 years of age because they observed higher success 
rates in older children. Morrissy et al.
32) concluded that 
a good result is unlikely in 6 year old patients that have 
failed to achieve union. The use of Ilizarov methods in 
children younger than 5 years has either failed to achieve 
union or resulted in almost immediate refracture.
4,6,31) A 
much higher refracture risk was also observed in patients 
younger than 4 years of age after the Ilizarov treatment 
compared to those older than 4 years, even though there 
was no difference in union rates according to age.
26) Based 
on this observation, we now prefer to perform definitive 
Ilizarov surgery on patients older than 3 years.
Fibular Stabilization 
The importance of fibular stabilization is emphasized be-
cause ankle valgus deformity caused by deficient lateral 
fibular support due to a fracture and/or concomitant fibu-
lar pseudarthrosis, or distal tibial wedging is strongly re-
lated to refracture.
2) Tudisco et al.
3) reported the functional 
results of 30 CPT patients at the end of skeletal growth, 
and concluded that the prognosis of CPT is related to the 
radiologic findings; patients with a severe limb length dis-
crepancy, poor ankle function, and fibular pseudarthrosis 
had the poorest functional results. Other authors also 
reported that persistent fibular pseudarthrosis is related 
to tibial union failure
8,11) and progressive ankle valgus.
6) 
Dobbs et al.
9) also found in their long-term follow-up 
study on the use of an intramedullary rod to treat CPT 
that most ankle valgus deformities occurred in patients 
with concomitant fibular pseudarthrosis, even after the 
fibular lesion had been treated. In a previous study,
26) 
based on a survival analysis approach, fibular stabilization 
by either tibiofibular synostosis or fibular osteosynthesis 
resulted in significantly better refracture-free survival than 
that experienced by those with a pseudarthrotic fibula 
due to neglect or failed synostosis. The hazard ratio of re-
fracture was 3.997 (95% confidence interval [CI], 1.218 to 
13.119) with fibular stability, but only 0.986 (95% CI, 0.977 
to 0.994) with the tibial cross-sectional area. Therefore, 
tibiofibular synostosis should be performed if necessary 
because the benefits outweigh the adverse effects. In con-
trast to common belief, Joseph and Mathew
29) and Fern et 
al.
28) showed that fibular surgery is unnecessary when an 
intramedullary rod is used, and reported union rates of 
83% and 100%, respectively, without fibular surgery. How-
ever, these authors used a technique of retrograde trans-
tarsal intramedullary rod placement across the ankle joint.
Johnston and Birch
24) recommended that a fibular 
osteotomy is necessary to achieve optimal limb alignment 
and union when the fibula is intact. They also recom-
mended that a hypoplastic or bowed fibula, which is sug-
gestive of pseudarthrosis, should be resected. We hold the 
view that a fibular osteotomy and shortening may be indi-
cated to accommodate length requirements at the time of 
acute tibial compression in selected cases, in which healing 
of the fibular osteotomy site is of little or no concern. Fibu-
lar osteotomy, if performed on the dysplastic fibula, can 
encourage iatrogenic fibular nonunion. The fibula should 
typically be stabilized by intramedullary fixation using a 
Kirschner wire or Steinmann pin, in order to accommo-
date the small diameter of the canal. 
Cross-Sectional Diameter of Healing 
One of the most important treatment principles is maxi-
mization of the cross-sectional area of healing at the level 
of the pseudarthrosis because this safeguards against 
refracture.
22) It is reasonable to assume that a wide cross-
sectional healing area better resists mechanical stresses. A 
previous study
26) reported that the risk of refracture was 
significantly higher in patients with a small cross-sectional 
area. Furthermore, the ratio of the smallest cross-sectional 
area of healing at the level of the pseudarthrosis relative 
to the cross-sectional area of the proximal metaphysis of 
the tibia is a valuable predictor of refracture (unpublished 
data). In other words, a narrow tibial shaft in the presence 
of a relatively wide proximal metaphysis increases the risk 
of refracture, regardless of age. This means that to reduce 
the risk of refracture, both the ratio of the cross-sectional 
areas of the metaphysis and shaft of the tibia and the ab-
solute value of the cross-sectional area of the tibial shaft 
at the pseudarthrosis level should be considered prior to 
surgery.
Use of Bone Morphogenetic Protein (BMP) 
In CPT patients associated with NF-1, it was observed that 
fibrous hamartoma cells maintained some of the mesen-
chymal lineage phenotype, and did not undergo osteoblas-
tic differentiation in response to BMP. Furthermore, these 
cells were more osteoclastogenic than normal tibial peri-
osteal cells.
33) Based on this observation, it is believed that 4
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fibrous hamartoma should be resected completely at the 
time of osteosynthesis. Two recent reports regarding the 
use of recombinant human BMPs administered as supple-
ments at the time of pseudarthrosis repair are intriguing. 
Richards et al.
34) reported radiographic union at an aver-
age of 33 weeks postoperatively in six of the seven patients 
who underwent Williams’ rodding, BMP-2 supplementa-
tion and autogenous iliac bone grafting. In this previous 
study, a BMP-soaked collagen sponge was wrapped around 
bone grafts placed circumferentially around pseudarthro-
sis sites, and a robust callus was observed at the pseudar-
throsis sites after the administration of rhBMP-2 without 
adverse effects. However, Lee et al.
35) reported healing 
failure in four out of five patients treated with external 
fixation in conjunction with an allograft-BMP-7-collagen 
carrier complex at the pseudarthrosis sites. In this study, 
resorption of the complex was observed with time, and the 
authors concluded that the use of BMP alone may not be 
sufficient to overcome the poor healing environment asso-
ciated with CPT. Our stance on this topic is that it may be 
reasonable to use rhBMPs as an adjunctive osteoinductive 
biologic material in CPT only after a complete excision of 
the fibrous hamartoma because fibrous hamartomatous 
tissue does not respond to BMP signaling. Time will pro-
vide an answer to the genuine efficacy of BMPs in CPT.
FIBULAR STATUS-BASED MULTI-TARGETED 
APPROACH USING THE ILIZAROV TECHNIQUE
The Ilizarov technique has been used in our hospital to 
treat CPT since 1989 with high union rates. However, 
during the first ten years, the management of co-existing 
fibular pseudarthrosis was often neglected, and the main 
focus was placed on tibial osteosynthesis, which we con-
sidered to contribute to ankle valgus and resultant refrac-
ture. During this period, when hypoplastic fibulae were 
osteotomized for length adjustment relative to the tibiae 
at the time of acute compression osteosynthesis, the os-
teotomized fibulae tended to remain non-united, which 
apparently contributed to refracture. In January 1999, we 
started to apply an algorithmic, multi-targeted approach, 
and paid greater attention to fibular management at the 
time of tibial osteosynthesis. This resulted in an increase in 
the refracture-free cumulative survival rate (unpublished 
data).
Classification of Fibular Status
The fibular status can be classified into two types (Fig. 1). 
Type A has normal fibular integrity in the presence of es-
tablished atrophic-type CPT, whereas type B has atrophic-
type CPT with concomitant fibular pseudarthrosis. These 
types can be subdivided further. Type A1 has a normal 
appearing fibula or mild dysplasia, whereas type A2 has 
moderate fibula dysplasia but without fracture or pseud-
arthrosis. Type B1 has mild dysplasia (> 50% of the width 
of the contralateral normal side) with little or no proximal 
migration of the distal fibular physis relative to the tibia. 
Type B2 shows moderate dysplasia with the atrophic ends, 
and mild proximal migration of the distal fibular physis 
relative to the tibia. Type B3 has a severely dysplastic fibula 
with atrophic ends, which is often associated with a nar-
row or obliterated medullary canal, and shows marked 
proximal migration of the distal fibular physis. 
The Authors’ Proposed Algorithmic Treatment Protocol 
(Fig. 2) 
In hypertrophic-type CPT, the closed compression or dis-
traction technique may be selectively indicated, whereas in 
atrophic-type CPT, the treatment strategy depends on the 
presence or absence of a coexisting fibular pseudarthrosis 
severity, the locations of dysplastic tibial and fibular pseud-
arthrosis, and the extent of leg length shortening. Bone 
Fig. 1. Classification of fibular status. Type A has normal fibular integrity 
in the presence of established atrophic-type congenital pseudarthrosis of 
the tibia (CPT), whereas type B has atrophic-type CPT with concomitant 
fibular pseudarthrosis. Type A1 has a fibula with a normal appearance or 
mild dysplasia, and type A2 has moderate fibula dysplasia but without 
fracture or pseudarthrosis. Type B1 has mild dysplasia (> 50% of the 
width of the contralateral normal side) with little or no proximal migration 
of the distal fibular physis relative to the tibia; type B2 shows moderate 
dysplasia with atrophic ends and mild proximal migration of the distal 
fibular physis relative to the tibia; whereas type B3 has a severely 
dysplastic fibula with atrophic ends, which is often associated with a 
narrow or obliterated medullary canal, and marked proximal migration of 
distal fibular physis.5
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transport of the tibia is advocated when no established 
fibular pseudarthrosis is present (type A) and the resection 
gap of the tibia is substantial. However, circumferential-
onlay bone grafting may be indicated if the resection gap 
is small. Furthermore, when residual leg length shortening 
after healing is expected to be < 2-3 cm, fibular osteotomy 
and shortening may be indicated to accommodate its 
length at the time of acute compression of the tibia. In this 
situation, the fibula should be stabilized by intramedullary 
fixation because of the potential nonunion of the fibula af-
ter osteotomy. A ‘4-in-1 osteosynthesis’ may be indicated if 
a fibular osteotomy is contemplated for a type A2 fibula in 
the presence of a thin tibial shaft at the level of the pseud-
arthrosis, as this would increase the cross-sectional area 
of healing. The term ‘4-in-1 osteosynthesis’ is used to de-
scribe the placing of all four proximal and distal segments 
of the tibia and fibula in one bone healing mass.
In type B with an established fibular pseudarthrosis, 
it is essential to apply different fibular management strate-
gies, which depend on the subtype. When the quality of 
the fibula is sufficient (type B1), end-to-end osteosynthesis 
of the fibula at the time of tibial osteosynthesis is preferred 
to restore normal ankle mortise. However, when the 
pseudarthrotic fibula is too dysplastic, all efforts should 
be made to stabilize the ankle either by using a ‘4-in-1 
osteosynthesis’ for type B2 (Fig. 3) or by distal tibiofibular 
fusion for type B3. Distal tibiofibular fusion (the Langen-
skiöld method) is indicated only for type B3 or when other 
techniques have failed. When proximal migration of the 
fibula is deemed too severe, the fibula can be pulled down 
to the corresponding level of the distal tibia using the 
pulling system of the Ilizarov device followed by second-
ary distal tibiofibular fusion. Therefore, distal tibiofibular 
fusion is considered primarily for ankle stabilization, 
whereas ‘4-in-1 osteosynthesis’ is considered for ankle sta-
bilization and union given the large cross-sectional area. 
Any technique that requires permanent ankle joint trans-
fixation should not be considered as a primary choice. ‘4-
in-1 osteosynthesis’ appears to have several advantages 
because it a) maximizes the cross-sectional area of healing 
at the pseudarthrosis level, b) facilitates bony healing due 
to autogenous bone grafting over a wider area, c) provides 
ankle stabilization and prevents proximal migration of the 
distal segment of the fibula, which causes ankle valgus, 
and d) preserves ankle mobility. 
When residual shortening > 2-3 cm is anticipated, 
Fig. 2. The author’s fibular status-based algorithmic approach for osteosynthesis, ankle stabilization and leg-length equalization. We advocate internal 
bone transport of the tibia when there is no established fibular pseudarthrosis (type A) and the resection gap of the tibia is substantial. Circumferential-
onlay bone grafting may be indicated if the resection gap is small. Fibular osteotomy and shortening may be indicated to accommodate its length at 
the time of acute compression of the tibia. When the quality of the fibula is sufficient (type B1), end-to-end osteosynthesis of the fibula at the time 
of tibial osteosynthesis is preferred to restore normal ankle mortise. However, when the pseudarthrotic fibula is too dysplastic, all efforts should be 
made to stabilize the ankle using either a ‘4-in-1 osteosynthesis’ for type B2 or by distal tibiofibular fusion for type B3. When more than 2-3 cm of 
residual shortening is anticipated, either the bifocal compression-distraction technique (acute resection, realignment, and compression with proximal 
lengthening) or internal bone transport is recommended. LLD: limb length discrepancy, BG: bone graft, TL: tibial lengthening, TF: tibiofibular.6
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either a bifocal compression-distraction technique (acute 
resection, realignment, and compression with proximal 
lengthening) or internal bone transport is recommended. 
For bone transport, the docking sites are debrided rou-
tinely by excising the interposing fibrous tissue to establish 
viable bleeding bone ends. The docking site is normally 
stabilized by cross-pinning in conjunction with copious 
autogenous bone grafting. Proximal tibial lengthening by 
distraction osteogenesis can be performed at the metaphy-
seal, physeal or subphyseal level. Proximal metaphyseal 
lengthening is indicated when there is no proximal tibial 
dysplasia and no previous lengthening history. In contrast, 
chondrodiatasis or subphyseal lengthening may be better 
indicated when there is obvious proximal tibial dysplasia 
or a previous lengthening history.
36) Furthermore, residual 
valgus deformities of the ankle and knee may benefit from 
timely medial hemiepiphysiodesis of the tibia to achieve 
guided-growth control.
We advocate utilizing a smooth Steinmann pin as 
an intramedullary rod primarily to help realign the tibial 
segments during the Ilizarov operation, and minimize the 
shearing force at the pseudarthrosis site during healing.
26) 
The rod can be removed after bony union when the affect-
ed lower leg regains perfect ground mechanical axis align-
ment in the absence of proximal tibial dysplasia and has a 
large cross-sectional area of healing mass. Otherwise, we 
prefer to retain the pin in the tibial medullary canal at the 
time of the Ilizarov frame removal. Nevertheless, retention 
of a rod across the previous pseudarthrosis should have 
biomechanical benefits, even though it cannot prevent the 
biological process underlying refracture. After healing, a 
total contact short leg brace is recommended until skeletal 
maturity because the risk of refracture persists until or af-
ter skeletal maturity. 
CONCLUSIONS
This review reaffirms that the Ilizarov technique is an ef-
fective, safe and practical treatment option for managing 
atrophic-type CPT. In contrast to other treatment modali-
ties, the Ilizarov technique allows multiple targets to be 
realized, i.e., osteosynthesis, ankle stabilization and leg-
length equalization. However, to minimize residual chal-
lenges after primary healing, optimum surgical interven-
tion based on the basic treatment principles is essential 
for obtaining and maintaining union while minimizing a 
Fig. 3. '4-in-1 osteosynthesis' for atrophic-type congenital pseudarthrosis of the tibia (CPT), with type B2 fibular pseudarthrosis. (A) Preoperative 
radiograph taken at age 6 years and 4 months. (B) Immediate postoperative radiograph showing a combined Ilizarov bifocal, distal compression and 
proximal distraction method and intramedullary nailing using the smooth Steinmann pin. Approximately 6 cm length gain could be obtained. (C) 
Radiograph taken at age 9 years showing a well-aligned tibia.7
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